Canatu

Canatu will publish its Half-Year Report for 1 January - 30 June 2026 on August 25, at approximately 9:00 am EEST. Our CEO Dr. Maximilian Slawinski and CFO Mikko Vesterinen will present the results and Canatu's business outlook in a live webcast on the same day from 12:00 noon to 1:00 p.m. EEST Register for the webcast here: https://lnkd.in/dYJCjmhJ

Inspiring future semiconductor talent at Canatu!   Yesterday we had the pleasure of welcoming a group of highly motivated and curious students from Aalto University's Semi-Summer 2026 programme to our headquarters and production facilities in Vantaa.   The visit offered a closer look at our carbon nanotube technology through technology workshops, discussions with our experts, and a factory tour showcasing how innovation moves from research to real-world applications. Semi-Summer is a collaborative initiative between Aalto University and leading semiconductor companies, including Applied Materials, Bosch Sensortec, Canatu, Murata, Okmetic and SiTime, helping students gain hands-on experience and explore career opportunities in Finland’s growing semiconductor industry.   A big thank you to Aalto University, the students, and everyone at Canatu who contributed to a successful day. We are excited to support and inspire the next generation of innovators!✨   Learn more about Semi-Summer: https://lnkd.in/dcCC2BE3 #SemiSummer2026 #Nanotechnology #Semiconductor #FutureTalent

We’re heading to SPIE Photomask + EUV Lithography this September. Meet our team throughout September 8–11 at the Monterey Conference Center to discuss the latest advancements and trends shaping the semiconductor industry. During the exhibition on September 9–10, we welcome everyone to visit us at booth 208, where we will showcase our latest solutions and products, including CNT membrane reactors, inspection membranes for EUV mask inspection, and spectral purity filters for EUV. We look forward to meeting partners and industry colleagues there. If you’re attending, we’d be glad to connect. Book a meeting with us: https://lnkd.in/d23UWmaV See you in Monterey! #SPIEPhotomaskEUV

We are looking forward to ADLM next week! This year, we will showcase our new-generation sensing platform based on carbon nanotubes that is being developed. It will bring lab-grade hormone results to the point-of-care, enabling regular monitoring and better-targeted patient treatments. Welcome to visit us at booth 1304, attend our poster sessions or arrange a meeting with Nedal Safwat or Ville Rajala to discuss how we can advance the future of medical diagnostics together. #ADLM2026 #PointOfCareTesting #HormoneTesting #CarbonNanotubes

Last week in London, our CEO, Dr. Maximilian Slawinski, spoke with Nitin Dahad from EE Times | Electronic Engineering Times about Canatu's journey, the expanding role of carbon nanotubes in next-generation technologies, and the opportunities ahead. In this interview, Maximilian reflects on the lessons learned from his career in materials science and technology industrialization, shares the vision behind Canatu, and discusses how we are building the foundation for broader adoption of carbon nanotubes to enable safer, more reliable, and more efficient technologies across semiconductor manufacturing, autonomous intelligent systems, defence, and medical diagnostics. Thank you to Nitin Dahad and the EE Times for the engaging discussion! 🎥 Watch the interview here: https://lnkd.in/enB9zwrp #Canatu #CarbonNanotubes #AdvancedMaterials #Leadership

Exciting updates in Canatu's executive leadership team. We are pleased to welcome Walter Braun as Chief Technology Officer (CTO) and Bernd Meier as Chief Marketing Officer (CMO), effective September 1, 2026. Walter brings more than 20 years of international leadership in industrial automation, semiconductor equipment, and advanced manufacturing systems. As CTO, he will lead the continued advancement and industrialization of Canatu's technology and products. Bernd joins with more than 25 years of commercial leadership across the semiconductor, industrial technology, and robotics industries. As CMO, he will lead Canatu's sales, marketing, and business development functions to accelerate global commercial growth. Together, Walter and Bernd bring deep expertise in technology, industrialization, and commercial scaling. Their appointments complete Canatu's executive leadership team, providing a strong foundation for further productization, international expansion, and commercial execution. Read more in the press release: https://lnkd.in/d6bWtvRU

Canatu is bringing a new spin to point-of-care - the sensitivity and speed of lab-grade testing at the point of need, powered by our Carbon Nanotube biosensor platform. We are excited to be exhibiting at ADLM 2026 on July 28-30. ADLM is a leading global event that advances innovation in clinical laboratory science and diagnostics, held in Anaheim, California. Visit us at booth 1304 to explore our technology and the opportunities to collaborate with us on the journey of building the future of medical diagnostics. Connect with Nedal Safwat or Ville Rajala to learn more and arrange a meeting. #ADLM2026 #medicaldiagnostics #pointofcare #hormonetesting #IVD #medtech #Canatu

Today, Canatu is announcing changes to its leadership structure, designed to drive efficiency and growth. The updated leadership team will comprise executive management members, business unit leaders, and operational leadership members, all of whom will report directly to CEO, Dr. Maximilian Slawinski. This model reinforces clear ownership and closer alignment between our business units and corporate functions while maintaining the agility needed to execute effectively across our markets. At the same time, we have renamed our Automotive business unit to Robotics, Mobility and Defence. The new name better reflects our current offering and the scope of the business unit’s activities. The changes are effective immediately and do not impact Canatu’s financial reporting. Read more: https://lnkd.in/dPvApwBC

Canatu has achieved ISO 13485:2016 certification, strengthening our readiness for medical diagnostics markets. ISO 13485 is the internationally recognized quality management standard for medical device and in vitro diagnostics (IVD) companies. The certification audit was completed with zero nonconformances, reflecting the strength and maturity of Canatu’s quality management system. This achievement strengthens our ability to develop next-generation point-of-care diagnostics technologies and provides an important foundation for future regulatory submissions and commercialization activities in major healthcare markets across the United States and Europe. A big thank you to our Medical Diagnostics and Quality teams, as well as everyone who contributed to this achievement. 🚀